11/20/23 18:34 | 11/20/23 | VIGL | Health | BioPrd | Biological Products, (No Diag | Magovcevic-Liebisch Ivana | MA | DO | P,CEO | P | 15 | 3.75 | 0 | 4 | 2 | 208 | D | | | | | | | | | | | | | | |
11/22/22 21:45 | 11/18/22 | VIGL | Health | BioPrd | Biological Products, (No Diag | Papapetropoulos Spyros | MA | O | Chief Me | M.d | 1 | 1.89 | 0 | 0 | 8 | 4 | D | | | | | | | | | | | | | | |
11/22/22 21:45 | 11/18/22 | VIGL | Health | BioPrd | Biological Products, (No Diag | Papapetropoulos Spyros | MA | O | Chief Me | S.d | -4 | 14.00 | 0 | 0 | -7 | 4 | D | | | | | | | | | | | | | | |
5/17/22 21:06 | 5/16/22 | VIGL | Health | BioPrd | Biological Products, (No Diag | Thorp Clay | MA | D | | P.m | 104 | 2.85 | 0 | 37 | 2 | 1,559 | I | | | | | | | | | | | | | | |
5/6/22 07:00 | 5/5/22 | VIGL | Health | BioPrd | Biological Products, (No Diag | Thackaberry Evan | MA | O | SVP,Head | P | 6 | 4.00 | 0 | 2 | New | 2 | D | | | | | | | | | | | | | | |
5/4/22 07:00 | 5/3/22 | VIGL | Health | BioPrd | Biological Products, (No Diag | Verni Christopher | MA | O | GC | P | 15 | 3.77 | 0 | 4 | New | 4 | D | | | | | | | | | | | | | | |
5/4/22 07:00 | 5/2/22 | VIGL | Health | BioPrd | Biological Products, (No Diag | Magovcevic-Liebisch Ivana | MA | DO | P,CEO | P.m | 18 | 3.68 | 0 | 5 | 3 | 204 | D | | | | | | | | | | | | | | |
5/4/22 07:00 | 5/3/22 | VIGL | Health | BioPrd | Biological Products, (No Diag | Ziolkowski Jennifer Lynn | MA | O | CFO | P | 15 | 3.77 | 0 | 4 | New | 4 | D | | | | | | | | | | | | | | |
5/4/22 07:00 | 5/3/22 | VIGL | Health | BioPrd | Biological Products, (No Diag | Papapetropoulos Spyros | MA | O | Chief Me | P | 14 | 3.40 | 0 | 4 | New | 4 | D | | | | | | | | | | | | | | |
3/28/22 16:44 | 3/28/22 | VIGL | Health | BioPrd | Biological Products, (No Diag | Thorp Clay | MA | D | | P | 22 | 7.20 | 0 | 3 | 0 | 1,522 | D | | | | | | | | | | | | | | |
1/11/22 21:20 | 1/11/22 | VIGL | Health | BioPrd | Biological Products, (No Diag | Thorp Clay | MA | D | | P.d | 3,710 | 14.00 | 0 | 265 | 21 | 1,519 | I | | | | | | | | | | | | | | |
1/11/22 21:18 | 1/11/22 | VIGL | Health | BioPrd | Biological Products, (No Diag | Vida Ventures Gp Iii, L.L.C. | MA | T | | P.d | 23,450 | 14.00 | 0 | 1,675 | 50 | 5,016 | I | | | | | | | | | | | | | | |
1/11/22 21:15 | 1/11/22 | VIGL | Health | BioPrd | Biological Products, (No Diag | Atlas Venture Fund Xii, L.P. | MA | T | | P.d | 7,490 | 14.00 | 0 | 535 | 10 | 5,837 | I | | | | | | | | | | | | | | |
1/11/22 21:11 | 1/11/22 | VIGL | Health | BioPrd | Biological Products, (No Diag | Booth Bruce | MA | D | | P.d | 7,490 | 14.00 | 0 | 535 | 10 | 5,837 | I | | | | | | | | | | | | | | |
1/11/22 21:11 | 1/11/22 | VIGL | Health | BioPrd | Biological Products, (No Diag | Vitorovic Stefan | MA | D | | P.d | 23,450 | 14.00 | 0 | 1,675 | 50 | 5,016 | I | | | | | | | | | | | | | | |
1/11/22 20:18 | 1/11/22 | VIGL | Health | BioPrd | Biological Products, (No Diag | Northpond Ventures Gp, LLC | MD | T | | P.d | 4,970 | 14.00 | 0 | 355 | 9 | 4,214 | I | | | | | | | | | | | | | | |